CSIMarket
 


Evolutionary Genomics Inc   (FNAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Evolutionary Genomics Inc 's Leverage Ratio

FNAM's quarterly Leverage Ratio and Total Liabilities, Equity growth




FNAM Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Liabilities Change 60.77 % 61.7 % 34.46 % 58.5 % 22.11 %
Leverage Ratio MRQ - - - - -
Overall Ranking Seq. Equity Change - - - - -
Seq. Total Liabilities Change 1.53 % 21.86 % 6.7 % 21.78 % 2.12 %



Leverage Ratio third quarter 2022 Comment
In III. Quarter Evolutionary Genomics Inc had stockholder deficit.

Within Medical Laboratories industry Evolutionary Genomics Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are FNAM Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Evolutionary Genomics Inc 's Equity $ -5 Millions Visit FNAM's Balance sheet
Evolutionary Genomics Inc 's Total Liabilities $ 10 Millions Visit FNAM's Balance sheet
Source of FNAM's Sales Visit FNAM's Sales by Geography


Cumulative Evolutionary Genomics Inc 's Leverage Ratio

FNAM's Leverage Ratio for the trailling 12 Months

FNAM Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth 60.77 % 61.7 % 34.46 % 58.5 % 22.11 %
Leverage Ratio TTM - - - - -
Total Ranking TTM Seq. Equity TTM Growth - - - - -
Seq. Total Liabilities TTM Growth 1.53 % 21.86 % 6.7 % 21.78 % 2.12 %


TTM Leverage Ratio Comment
On the trailing twelve months basis In the III. Quarter company had stockholder deficit.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Laboratories industry FNAM recorded the lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Leverage Ratio?
Who are FNAM Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry #
Healthcare Sector #
Within the Market #


TTM Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Medical Laboratories Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity

Date modified: 2022-10-22T16:52:04+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

META's Profile

Stock Price

META's Financials

Business Description

Fundamentals

Charts & Quotes

META's News

Suppliers

META's Competitors

Customers & Markets

Economic Indicators

META's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071